Platelets contribute to disease severity in COVID-19.
Tessa J BarrettSeda BilalogluMacintosh CornwellHannah M BurgessVitor W VirginioKamelia DrenkovaHomam IbrahimEugene YuriditskyYin AphinyanaphongsMark LifshitzFeng Xia LiangJulie AlejoGrace SmithStefania PittalugaAmy V RapkiewiczJun WangCamelia Iancu-RubinIan MohrKelly RugglesKenneth A StaplefordJudith HochmanJeffrey S BergerPublished in: Journal of thrombosis and haemostasis : JTH (2021)
Platelet count, size, and maturity associate with increased critical illness and all-cause mortality among hospitalized COVID-19 patients. Profiling tissues and blood from COVID-19 patients revealed that SARS-CoV-2 virions enter megakaryocytes and platelets and associate with alterations to the platelet transcriptome and activation profile.